CRP and ulcerative colitis: reported increased blood levels of HMGB1 in patients with Crohn’s disease and ulcerative colitis, but they saw no association with disease activity.11 Likewise, they found no association between anti-HMGB1 Abs in blood and disease activity markers (CRP, f-calprotectin and SES-CD).